Aurobindo Pharma USA Inc 2024-08-28 Health critical FDA
Health · FDA · Recall #FDA-D-0641-2024
Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65… Recall
Issued August 28, 2024 · Aurobindo Pharma USA Inc
In August 2024, Aurobindo Pharma USA Inc recalled the Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
What you should do
- 1 Stop using Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Aurobindo Pharma USA Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Aurobindo Pharma USA Inc
- Category
- Health
- Recall date
- August 28, 2024
- Units affected
- Not reported
- Sold at
- NJ, NY & PA
- Recall number
- FDA-D-0641-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Aurobindo Pharma USA Inc has 3 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.